Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela

International Journal of Cancer

Volumn 119, Issue 7, 2006, Pages 1666-1671

  Kato, Ikuko ^a,b,g   Van Doorn, Leen Jan ^c   Canzian, Federico ^d,e   Plummer, Martyn ^d   Franceschi, Silvia ^d   Vivas, Jorge ^f   Lopez, Gladys ^f   Lu, Yanhui ^d   Gioia Patricola, Lydie ^d   Severson, Richard K ^a   Schwartz, Ann G ^a,b   Muñoz, Nubia ^d  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DDL DIAGNOSTIC LABORATORY   (Netherlands)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f Cancer Control Center of the Tachira State   (Venezuela)

^g KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Cytokines; Genetic polymorphisms; Helicobacter pylori; Premalignant lesions; Stomach cancer

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; ATROPHIC GASTRITIS; CARCINOGENESIS; DYSPLASIA; GENETIC POLYMORPHISM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEREDITY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; PRECANCER; PREVALENCE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH MUCOSA; VENEZUELA;

ALLELES; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; POLYMORPHISM, GENETIC; PRECANCEROUS CONDITIONS; RISK FACTORS; STOMACH NEOPLASMS; VENEZUELA;

EID: 33747497718     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21979     Document Type: Article

References (51)

1. Arora S, Czinn SJ. Vaccination as a method of preventing Helicobacter pylori-associated gastric cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1890-1.
2. IARC. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 61: schistosomes, liver flukes and Helicobacter pylori. Lyon: IARC, 1994.
3. Jung HC, Kim JM, Sing IS, Kim CY. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of raRNA for interleukin-8, -1 α/β, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumor necrosis factor-α. J Gastroenterol Hepatol 1997;12:473-80.
4. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, Tannenbaum S, Collazos T, Ruiz B. The gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 1990;50:4731-6.
5. Martin Guerrero JM, Hergueta Delgado P, Esteban Carretero JJ, Rivera Hueto FF, Pellicer Bautista FJ, Herrerias Gutierrez JM. Pathogenic implications of interleukin-8 activity and bacterial phenotype in antral gastritis associated with Helicobacter pylori. Rev Esp Enferm Dig 2000;92:301-15.
6. Harris PR, Mobley HL, Perez-Perez GI, Blaser MJ, Smith PD. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996;111:419-25.
7. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994;55:97-179.
8. + Helicobacter pylori infection and inflammation. Dig Dis Sci 2001;46:836-44.
9. Naito Y, Yoshikawa T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic Biol Med 2002;33:323-36.
10. De Luca A, Iaquinto G. Helicobacter pylori and gastric diseases: a dangerous association. Cancer Lett 2004;213:1-10.
11. Mukaida N, Harada A, Yasumoto K, Matsushima K. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microbiol Immunol 1992;36:773-89.
12. Mori N, Ueda A, Geleziunas A, Wada A, Hirayama T, Yoshimura T, Yamamoto N. Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-κ B. Infect Immun 2001;69:1280-6.
13. Dinarello CA. The biology of interleukin 1. Chem Immunol 1992;51:1-32.
14. El-Omar EM. The importance of interleukin 1β in Helicobacter pylori associated disease. Gut 2001;48:743-7.
15. Makhatadze NJ. Tumor necrosis factor locus: genetic organization and biological implications. Hum Immunol 1998;59:571-9.
16. Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H. Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res 1999;59:4516-18.
17. Wong PKK, Campbell IK, Egan PJ, Ernst M, Wicks IP. The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum 2003;48:1177-89.
18. Muñoz N, Vivas J, Buiatti E, Kato I, Oliver W. Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of the study design and baseline data. In: Stewart BW, McGregor D, Kleihues P, eds. Principles of chemoprevention. Lyon: IARC, 1996. IARC Science Publication No. 139,125-33.
19. Muñoz N, Kato I, Peraza S, Lopez G, Carrillo E, Ramirez H, Vivas J, Castro D, Sanchez C, Buiatti E, Oliver W. Prevalence of precancerous lesions of the stomach in Venezuela. Cancer Epidemiol Biomarkers Prev 1996;5:41-6.
20. van Doom LJ, Figueiredo C, Rossau R, Jannes G, van Asbroeck M, Sousa JC, Carneiro F, Quint W. Typing of the Helicobacter pylori vacA gene and detection of the cagA gene by PCR and reverse hybridization. J Clin Microbiol 1998;36:1271-6.
21. Lu Y, Gioia-Patricola L, Gomez JV, Plummer M, Franceschi S, Kato I, Canzian F. Use of whole genome amplification to rescue DNA from plasma samples. Biotechniques 2005;39:511-15.
22. Allion PD. Logistic regression using the SAS system: theory and application. Cary, NC: SAS Institute, 1999. Ch. 5, 103-32.
23. Kato I, Vivas J, Plummer M, Lopez G, Peraza S, Castro D, Sanchez V, Cano E, Andrade O, Garcia R, Franceschi S, Oliver W, Muñoz N. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev 2004;13:468-76.
24. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact test of Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:887-93.
25. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor α and risk of gastric cancer in Chinese population. Carcinogenesis 2005;26:631-6.
26. Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, Koike T, Sekine H, Ohara S, Shimosegawa T. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005;54:330-5.
27. Savage SA, Abnet CC, Mark SD, Qiao YL, Dong ZW, Dawsey SM, Taylor PR, Chanock SJ. Variants of the IL-8 and IL-8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2004;13:2251-7.
28. Lee WP, Tai DI, Lan KH, Li AF, Hsu HC, Lin EJ, Lin YP, Sheu ML, Li CP, Chang FY, Chao Y, Yen SH et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 2005;11:6431-41.
29. El-Omar EM, Carrington M, Choe W-H, McCoIl KEL, Bream JH, Young HA, Herrera J, Lissowska J, Yuan C-C, Rothman N, Lanyon G, Martin M et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;304:398-402.
30. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro Alves C, Campos ML, van Doom LJ, Caldas C, Seruca R, Carneiro F et al. A proinflammatory genetic profile increases the risk for chronic atrophie gastritis and gastric carcinoma. Gastroenterology 2003; 125:364-71.
31. Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M, Sung JJ. Association of interleukin IB gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 2003;52:1684-9.
32. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF, Jr, Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193-201.
33. Garza-Gonzalez E, Bosques-Padilla FJ, El-Omar E, Hold G, Tijerina-Menchaca R, Maldonado-Garza HJ, Perez-Perez GI. Role of the polymorphic IL-IB, IL-IRN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005;114:237-41.
34. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N. Association of the interleukin-1β genetic polymorphism and gastric cancer risk in Japan. J Gastroenterol 2001;36:696-9.
35. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associated with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003;104:617-23.
36. Hwang IR, Hsu PI, Peterson LE, Gutierrez O, Kim JG, Graham DY, Yamaoka Y. Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases. Helicobacter 2003;8:142-8.
37. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000;55:1023-7.
38. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley IJ, Rappuoli R. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 1995;48:41-5.
39. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doom LJ, Carneiro F, Sobrinho-Simoes M. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680-7.
40. Rad R, Prinz C, Neu B, Neuhofer M, Zeitner M, Voland P, Becker I, Schepp W, Gerhard M. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003; 188:272-81.
41. Yamaoka Y, Kudo T, Lu H, Casola A, Brasier AR, Graham DY. Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology 2004;126:1030-43.
42. Brandt S, Kwok T, Hartig R, Konig W, Backert S. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA 2005;102:9300-5.
43. Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol 2001;42:631-44.
44. Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, Ishikawa S, Higuchi M, Takahashi A, Kurashima Y, Teishikata Y, Tanaka S, Azuma T et al. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 2004;279:17205-16.
45. Zhu YM, Webster SJ, Flower D, Woll PJ. Interleukin-8/CXCL8 is a growth factor for human lung cancer cell. Br J Cancer 2004;91:1970-6.
46. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003;125:1636-44.
47. Konturek SJ, Starzynska T, Konturek PC, Karczewska E, Marlicz K, Lawniczak M, Jaroszewicz-Heigelman H, Bielanski W, Hartwich A, Ziemniak A, Hahn EG. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer. Scand J Gastroenterol 2002;37:891-8.
48. Sun Y, Li J-Y, He J-S, Zhou L-X, Chen K. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma in the stomach. Histopathology 2005;46:505-14.
49. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997;34:391-9.
50. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001;21:1458-63.
51. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-I expression. Biochem Biophys Res Commun 1999;259:344-3.